Reuters: Exforge cuts black patients' blood pressure: Novartis

[NaDiNe]

Exforge cuts black patients' blood pressure: Novartis
      

ZURICH (Reuters) - Novartis AG's Exforge drug significantly reduced blood pressure in difficult-to-treat black patients, the Swiss drugmaker said on Wednesday, citing a clinical trial.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login